Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05020873 |
|---|---|
| Brief Title: | Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and India (SPOTLIGHT) |
| First Submitted : | August 19, 2021 |
| First Submitted that Met QC Criteria : | August 19, 2021 |
| First Posted : | August 25, 2021 |
| Last Update Submitted that Met QC Criteria : | January 12, 2023 |
| Last Update Posted : | January 13, 2023 |